About
About Guangdong Biolight Meditech Co., Ltd
Guangdong Biolight Meditech Co., Ltd. engages in the research and development, production, sale, and service of medical devices products and solutions in China. It operates in two segments, Life Information and Support, and Kidney Disease. The company offers emergency and critical care monitor, subcritical care monitor, general ward monitor, outpatient monitor, neonatal monitor, infusion pump, electrocardiograph, maternal and fetal monitor, defibrillator, multifunctional suspension device, internet of things, and central station; hemodiafiltration equipment, peritoneal dialysis equipment, liquid supply system, and hemodialysis water equipment; and finger clip oximeter, sphygmomanometer, fetal heart rate monitor, body temperature monitoring system, and home medical mall, as well as hemoperfusion devices, high throughput and low flu hemodialyzer, hemodialysis concentrate, dry powder, citric acid disinfectant, tube/puncture needle, dialysate filter, and dialysis fluid filter. It offers its products under JUNKANG MEDICAL, BIOLIGHT HEALTHCARE, TRUSTRONG, BR Medical Service, SHENBA, HUA VUE MEDICAL, BOAO TIANSHENG, and other brand names. The company serves medical institutions through direct sales channel. It also exports its products. The company was founded in 1993 and is headquartered in Zhuhai, China.
Research context
Guangdong Biolight Meditech Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Visit company website
5 years, 6 months ago
Guangdong Biolight Meditech Co., Ltd is currently in a long term downtrend where the price is trading 22.2% below its 200 day moving average.
From a valuation standpoint, the stock is 70.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.8.
Guangdong Biolight Meditech Co., Ltd's total revenue rose by 44.3% to $325M since the same quarter in the previous year.
Its net income has increased by 169.3% to $75M since the same quarter in the previous year.
Finally, its free cash flow fell by 101.7% to $-311K since the same quarter in the previous year.
Based on the above factors, Guangdong Biolight Meditech Co., Ltd gets an overall score of 3/5.